The discovery that expansion of a hexanucleotide repeat within a noncoding region of the C9orf72 gene causes amyotrophic lateral sclerosis and frontotemporal dementia raised questions about C9orf72 protein function and potential disease relevance. The major predicted structural feature of the C9orf72 protein is a DENN (differentially expressed in normal and neoplastic cells) domain. As DENN domains are best characterized for regulation of specific Rab GTPases, it has been proposed that C9orf72 may also act through regulation of a GTPase target. Recent genetic and cell biological studies furthermore indicate that the C9orf72 protein functions at lysosomes as part of a larger complex that also con- 
The discovery that expansion of a hexanucleotide repeat within a noncoding region of the C9orf72 gene causes amyotrophic lateral sclerosis and frontotemporal dementia raised questions about C9orf72 protein function and potential disease relevance. The major predicted structural feature of the C9orf72 protein is a DENN (differentially expressed in normal and neoplastic cells) domain. As DENN domains are best characterized for regulation of specific Rab GTPases, it has been proposed that C9orf72 may also act through regulation of a GTPase target. Recent genetic and cell biological studies furthermore indicate that the C9orf72 protein functions at lysosomes as part of a larger complex that also contains the Smith-Magenis chromosome region 8 (SMCR8) and WD repeat-containing protein 41 (WDR41) proteins. An important role for C9orf72 at lysosomes is supported by defects in lysosome morphology and mTOR complex 1 (mTORC1) signaling arising from C9orf72 KO in diverse model systems. Collectively, these new findings define a C9orf72-containing protein complex and a lysosomal site of action as central to C9orf72 function and provide a foundation for the elucidation of direct physiological targets for C9orf72. Further elucidation of mechanisms whereby C9orf72 regulates lysosome function will help to determine how the reductions in C9orf72 expression levels that accompany hexanucleotide repeat expansions contribute to disease pathology.
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| INTRODUCTION
In this review, we will first provide a brief overview of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). This will be followed by a discussion of the C9orf72 mutations that cause ALS-FTD and the major questions that have arisen concerning disease mechanisms. We will then explore in more depth new insights into the function of the C9orf72 protein. This includes an overview of the predicted structural similarity between C9orf72 and folliculin (FLCN), the Birt-Hogg-Dubé syndrome tumor suppressor that has suggested a role for C9orf72 as a GTPase-regulating protein. We will furthermore summarize recent insights into the function of the C9orf72 protein with particular focus on the identification of C9orf72-interacting proteins and alterations in lysosome cell biology arising from C9orf72 knockout studies in both mice and human cells. Finally, we will conclude with a discussion of additional genes related to lysosomal function that also contribute to ALS-FTD risk.
| ALS-FTD DISEASE SPECTRUM
ALS and FTD are lethal adult onset neurodegenerative diseases that predominantly affect the survival of motor neurons and distinct populations of cortical neurons, respectively. While these diseases were long thought to be distinct based on the major motor versus cognitive deficits that they elicit, it is now appreciated that ALS and FTD frequently share overlapping patient symptoms, cellular pathology and genetic origins. Figure 1A) . 33, 34 In particular, C9orf72 was predicted to have closest structural similarity to key FLCN-binding partners known as FLCN-interacting proteins 1 and 2 (FNIP1/2), 2 highly similar proteins that were originally discovered for their ability to robustly interact with FLCN, but whose structural similarity to FLCN was only brought to light by the same analysis that introduced C9orf72 to the DENN domain family.
A crystal structure of the N-terminal region of Lst4, the yeast orthologue of FNIP1/2, has since been solved that supports the prediction that FNIP proteins are indeed members of the DENN family. 37 Of additional interest, another protein of previously unknown function, Smith-Magenis chromosome region 8 (SMCR8) was predicted to be most structurally similar to FLCN. 33, 34 Collectively, the C9orf72, SMCR8, FLCN and FNIP1/2 proteins define a previously unappreciated branch of the DENN domain family tree ( Figure 1A ).
| REGULATION OF Rab GTPase NUCLEOTIDE BINDING STATUS BY DENN DOMAIN PROTEINS
At least 26 proteins are predicted to contain a DENN domain. 38 The best-characterized function for DENN domains is to act as guanine nucleotide exchange factors (GEFs) for members of the Rab family of and C9orf72 that illustrates that the DENN domain represents the major folded element in each of these proteins. Also noted at the N-terminal region of each of these DENN domains is a region that has similarity to the Longin domain that is found in many GTPase-regulating proteins. B, WDR41 is predicted to contain 8 WD40 repeats 62 . C, Schematic diagram summarizing functions and lysosomal localization of the C9orf72:SMCR8: WDR41 and FLCN:FNIP complexes.
GDI and its redistribution back into the cytosol. 44, 45 The predicted presence of a DENN domain in C9orf72 thus suggests a role for 
| A PROTEIN COMPLEX CONTAINING C9orf72, SMCR8 AND WDR41
The predicted structural similarity between C9orf72 and the FLCN:
FNIP heterodimer suggested that C9orf72 might form a complex with a second DENN domain-containing protein.
The analyses that built on the FLCN crystal structure to predict DENN domains in C9orf72 and the FNIPs also identified SMCR8 as having a DENN domain that had previously escaped detection due to low primary sequence similarity with other DENN proteins ( Figure 1A ). However, even while nothing was known about SMCR8, the predictions that it had structural similarity to C9orf72, FLCN and FNIPs turned out to be prescient; both unbiased proteomics approaches to identify repeat-containing protein with a predicted beta-propeller structure ( Figure 1B) . [55] [56] [57] [58] 62 The presence of WDR41 (as well as SMCR8) on lysosomal membranes was detected in a previous proteomics study 63 55 Note however that such interactions do not occur at the same high stoichiometry as those that support the stable formation of the C9orf72:SMCR8:WDR41 core components but are still likely to exert regulatory functions on the complex. Along these lines, it is noteworthy that the interaction between C9orf72 and ULK1 is enhanced under starvation conditions and knockdown of SMCR8 results in a modest increase in total ULK1 protein levels. 58 In addition to the association with these kinases, SMCR8 is also a target of mTORC1-dependent phosphorylation. 65 These findings also raise interesting parallels with the FLCN:FNIP complex. FNIP1 and FNIP2 bind the energy sensing kinase AMPK, and FNIP1 is phosphorylated in an AMPK-and mTOR-dependent manner. 50 In addition, FLCN can also be phosphorylated by ULK1. 66 The functional significance of these similarities concerning kinase interactions and phosphorylation of the C9orf72 and FLCN complexes remains poorly understood. It is likely that new structural insights into the organization of these protein complexes that reveal the locations of interaction interfaces and sites of phosphorylation will be required to fully address these problems. More specifically, an accumulation of enlarged lysosomes was observed in mouse C9orf72 KO macrophages, and microglia. 56, 68 Mice lacking C9orf72 also exhibited increased levels of SQSTM1/p62
| C9orf72 KO RESULTS IN LYSOSOME DEFECTS IN MULTIPLE EXPERIMENTAL SYSTEMS
and LC-3 (critical proteins involved in autophagy), potentially indicating an increase in autophagy or a defective clearance of autophagosomes by lysosomes. 60, 68 Of additional interest, pathway analysis of genes coexpressed with C9orf72 revealed enrichment for genes involved in lysosome function. 68 Given the major role played by lysosomes in professional scavenger cells in the degradation and recycling of phagocytosed material, such cells are particularly sensitive to defects in lysosome function. 69 Key roles for C9orf72 in ensuring the lysosomal function of microglia is of particular interest with respect to neurodegenerative disease given recent insights into potentially important roles played by microglial progranulin (an FTD gene) in the regulation of synaptic pruning. 70 While there is good reason to focus on C9orf72 functions in macrophages and microglia, in addition to these monocyte lineage phenotypes, defects in both T and B cells have also been reported in C9orf72 KO mice.
71,72
The nonneuronal lysosome phenotypes that were identified in C9orf72 KO mice raise the interesting possibility that reduced 
| C9orf72 LOCALIZES TO LYSOSOMES
Understanding the subcellular localization of C9orf72 and its regulation is likely to be key to understanding its direct functions. Unfortunately, the combination of limited antibody availability, low protein abundance and lack of KOs to serve as negative controls for staining specificity long presented challenges to addressing the localization of the endogenous C9orf72 protein. Likewise, elucidation of C9orf72 localization via over-expression of tagged proteins is challenging due to the potential need for matching levels of SMCR8 and/or WDR41.
This important problem was recently solved through the use of a CRISPR-Cas9 mediated genome editing strategy that inserted an epitope tag into the endogenous C9orf72 gene in cultured human cells. 59 This strategy enabled the detection of a specific immunofluorescence signal that was robustly enriched on the surface of lysosomes when cells were starved of amino acids but dispersed from the lysosome within minutes of amino acid refeeding. 59 This localization of C9orf72 was highly selective for lysosomes and did not strongly overlap with related organelles such as autophagosomes. Localization of C9orf72 to lysosomes nicely parallels the lysosomal phenotypes arising from the C9orf72 KO (see above) and is consistent with the lysosome being an important site of direct functions for C9orf72. In addition to this recent direct demonstration of lysosomal localization for C9orf72, the co-occurrence of both SMCR8 and WDR41 on lysosomes is supported by proteomic analysis of purified lysosomal membranes. 63 The negative regulation of C9orf72 lysosome recruitment by intracellular amino acid availability strikingly parallels the behavior of the related FLCN:FNIP protein complex. 51, 59 However, unlike FLCN:
FNIP, which directly binds to and regulates the lysosome-localized Rag GTPases, 51, 52 the mechanisms that support lysosomal localization and functions of the C9orf72 complex are currently unknown.
Related to this topic, unlike FLCN:FNIP, which shows regulated interactions with the Rags and which robustly controls the ability of Rags to recruit mTORC1 to lysosomes, C9orf72 does not coimmunoprecipitate with Rags and mTOR recruitment to lysosomes is intact in the absence of either C9orf72 or SMCR8. 51, 59 Key questions thus remain unanswered about the mechanisms whereby amino acid sensing is coupled to regulation of C9orf72 localization as well as molecular links between C9orf72 localization to lysosomes and the regulation of mTOR signaling.
The localization of C9orf72 to lysosomes may shed light on recent findings relating to C9orf72 and TMEM106b. 75 Human genetics identified a common TMEM106b variant that protects against FTD risk in both progranulin (also a protein of lysosomes) mutation and C9orf72 repeat expansion carriers. [76] [77] [78] [79] While the specific function of TMEM106b is not clear, it is a lysosome/late endosomelocalized type II transmembrane protein whose overexpression induces a pronounced swelling of these organelles along with defects in their acidification and degradative function. 80, 81 A functional connection between TMEM106b and C9orf72 is supported by the suppression of these TMEM106b over-expression phenotypes in C9orf72-depleted cells. 80 
| PUTATIVE GTPase TARGETS OF C9orf72
As summarized above, major functions of C9orf72 are likely to be mediated by the lysosome-localized C9orf72:SMCR8:WDR41 protein complex. The predicted presence of DENN domains in both C9orf72
and SMCR8 as well as similarity to the FLCN:FNIP complex suggest that the direct functions of C9orf72:SMCR8:WDR41 are likely to be mediated through GTPase regulation. Indeed, multiple Rabs have been proposed as putative C9orf72 targets. These include Rab1, Rab5, Rab7 and Rab11 which were found to interact with C9orf72. 82 However, a subsequent study failed to recapitulate these interactions but instead found Rabs 8a and 39b were the strongest Rab interactors of C9orf72 while weaker interactions were detected for RAB6a, RAB12, RAB25, RAB33a and RAB38. 55 In support of a role for
C9orf72 as a GEF for Rab8a and Rab39b, recombinant C9orf72 as well as the whole C9orf72:SMCR8:WDR41 complex stimulated exchange of GDP for GTP on these Rabs in an in vitro assay. 55 The GEF activity of the complex toward Rab39b was also reported independently. 58 These observations are consistent with a role for C9orf72 and/or the larger protein complex as a Rab8a and Rab39b
GEF. However, there are previously published examples of putative GEF-Rab pairs that fulfilled such binding and in vitro GEF activity criteria but were ultimately found not to be physiologically relevant. For example, FLCN was proposed to act as a Rab35 GEF based on in vitro assays 36 but was later shown to function at lysosomes 51 as a RagC GAP. 52 Likewise, in vitro assays initially supported a role for DENN2B as a Rab9 GEF 83 but a more in depth analysis later demonstrated a physiological function as a Rab13 GEF. 84 With past lessons in mind, several additional experiments would help to rigorously test the model that C9orf72 is a bona fide GEF for Rabs 8a and/or 39b. As it is a broadly conserved property for GEFs to preferentially interact with the nucleotide-free form of their target GTPase, 42, 43 it is predicted that C9orf72 should preferentially bind to Rab8a or 39b mutants that mimic this state. However, contrary to this expectation, it was reported that the C9orf72 complex did not discriminate between interacting with wild type versus GDP/nucleotide-free or GTP-locked Rab8a and 39b mutants. 55 Likewise, as the GTP loading of Rab GTPases is tightly coupled to their recruitment to target membranes, the subcellular localization of their GEFs defines Rab localization. 85 However, it has yet to be shown that C9orf72, either alone or in complex with SMCR8 and WDR41, is required for the membrane recruitment of either Rab8a or Rab39b. Likewise, as
C9orf72 is found on lysosomes, 59 it is predicted that if it functions as a Rab GEF, that it should promote the recruitment of its target GTPase to lysosomes. However, it has yet to be established that either Rab8a or Rab39b are enriched on C9orf72-positive lysosomes.
Instead, Rab8a has been reported to reside on recycling endosomes and Golgi 86 while Rab39b localizes to the Golgi. 87 Ultimately, the mechanism of any GEF activity for C9orf72 would need to be understood at the structural level as was previously established for DENND1B-Rab35. 35 The net effect of the various mechanisms through which C9orf72 can affect autophagy remains unclear as both increases 58, 60 and decreases in autophagy 55, 56 have been reported in C9orf72- 
| LYSOSOMES AND ALS-FTD GENETICS
With newfound appreciation of functions for C9orf72 in the autophagy-lysosome pathway, it is natural to ask whether the loss of such functions contributes to ALS-FTD risk in people with C9orf72 hexanucleotide repeat expansions and how such loss-of-function might synergize with gain-of-function defects that arise in parallel.
While a definitive answer to these questions is still lacking, it is inter- signaling suggest the potential for much broader physiological and pathophysiological functions that remain to be investigated.
| CONCLUSIONS

